FR2399840A1 - Application de la 2-cyano-aziridine et de ses derives a l'immunostimulation - Google Patents

Application de la 2-cyano-aziridine et de ses derives a l'immunostimulation

Info

Publication number
FR2399840A1
FR2399840A1 FR7823683A FR7823683A FR2399840A1 FR 2399840 A1 FR2399840 A1 FR 2399840A1 FR 7823683 A FR7823683 A FR 7823683A FR 7823683 A FR7823683 A FR 7823683A FR 2399840 A1 FR2399840 A1 FR 2399840A1
Authority
FR
France
Prior art keywords
aziridine
cyano
derivatives
application
immunostimulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7823683A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of FR2399840A1 publication Critical patent/FR2399840A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention est relative à une application de la 2-cyano-aziridine et de ceux de ses dérivés qui libèrent, dans des conditions physiologiques, de la 2-cyano-aziridine, caractérisée en ce que l'on utilise ces composés pour provoquer une activité immunostimulante. Elle concerne également un agent pharmaceutique contenant les substances actives définies dans la revendication 1.
FR7823683A 1977-08-12 1978-08-11 Application de la 2-cyano-aziridine et de ses derives a l'immunostimulation Withdrawn FR2399840A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772736296 DE2736296A1 (de) 1977-08-12 1977-08-12 Verwendung von 2-cyan-aziridin und seinen derivaten zur immunstimulierung

Publications (1)

Publication Number Publication Date
FR2399840A1 true FR2399840A1 (fr) 1979-03-09

Family

ID=6016187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7823683A Withdrawn FR2399840A1 (fr) 1977-08-12 1978-08-11 Application de la 2-cyano-aziridine et de ses derives a l'immunostimulation

Country Status (8)

Country Link
AU (1) AU3888678A (fr)
BE (1) BE869686A (fr)
DE (1) DE2736296A1 (fr)
FI (1) FI782419A (fr)
FR (1) FR2399840A1 (fr)
GB (1) GB1573730A (fr)
NL (1) NL7808275A (fr)
SE (1) SE7808520L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352652A2 (fr) * 1988-07-28 1990-01-31 Roche Diagnostics GmbH Utilisation de l'imexone comme immunosuppresseur

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369119A (en) * 1988-07-28 1994-11-29 Boehringer Mannheim Gmbh Use of imexon as an immune suppressive and pharmaceutical compositions containing imexon

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2644820A1 (de) * 1976-10-05 1978-04-06 Boehringer Mannheim Gmbh Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
DE2656323A1 (de) * 1976-12-11 1978-06-15 Boehringer Mannheim Gmbh L-aziridin-carbonsaeure-derivate und verfahren zu ihrer herstellung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2644820A1 (de) * 1976-10-05 1978-04-06 Boehringer Mannheim Gmbh Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
DE2656323A1 (de) * 1976-12-11 1978-06-15 Boehringer Mannheim Gmbh L-aziridin-carbonsaeure-derivate und verfahren zu ihrer herstellung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352652A2 (fr) * 1988-07-28 1990-01-31 Roche Diagnostics GmbH Utilisation de l'imexone comme immunosuppresseur
EP0352652A3 (fr) * 1988-07-28 1991-09-04 Roche Diagnostics GmbH Utilisation de l'imexone comme immunosuppresseur

Also Published As

Publication number Publication date
NL7808275A (nl) 1979-02-14
BE869686A (fr) 1979-02-12
SE7808520L (sv) 1979-02-13
GB1573730A (en) 1980-08-28
DE2736296A1 (de) 1979-02-22
AU3888678A (en) 1980-02-21
FI782419A (fi) 1979-02-13

Similar Documents

Publication Publication Date Title
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
FR2422402A1 (fr) Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale
PT83872A (de) Arzneimittel
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
TR199902529T2 (xx) Etkinle�tirilmi� protein C form�lasyonlar�.
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
NL990031I2 (nl) Farmaceutisch preparen die N-gesubstitueerde 3-hydroxypyrid-2-on of 4-onderrivaten bevatten.
FR2442851A1 (fr) Nouvelles spiro(4 h-2,3-dihydrovenzopyranne(4,5')oxazolidine)-2',4'-diones et medicament en contenant
DE3575076D1 (de) Katheter fuer rueckinfusion von pharmazeutischen agenten.
FR2402640A1 (fr) Nouveaux phenols a substituant hydroxyalkyle ou oxoalkyle et composition pharmaceutique les contenant
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
ATE16394T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
FR2432519A1 (fr) Nouveaux derives de purine et medicament les contenant
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
FR2398067A1 (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
FR2379549A1 (fr) 4''-deoxy-4''-(amino substitue)-oleandomycines et medicament les contenant
IT1213141B (it) Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
FR2399840A1 (fr) Application de la 2-cyano-aziridine et de ses derives a l'immunostimulation
FR2426039A1 (fr) Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant
OA08130A (fr) Compositions pharmaceutiques ou vétérinaires contenant des dérivés thiosulfonates.
DE69104608D1 (de) Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
ES2059633T3 (es) 2-terc.-butil-4-cloro-5-(4-terc.-butilbenciltio)-3(2h)-piridazinona para la lucha contra los moluscos.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
FR2394539A1 (fr) Nouveaux derives substitues en position 15 d'o-pentanorprostaglandine et leur utilisation comme medicament

Legal Events

Date Code Title Description
ST Notification of lapse